Repligen will acquire BioLife Solutions for $1.5 billion, merging two longtime providers of tools for cell and gene therapy and biopreservation. The deal values BioLife shares at $31 each and is slated to close in the fourth quarter pending approvals.
BioLife develops biopreservation products for cell and gene therapy.
Cell and gene therapies treat disease at the molecular level.
Tap a lens to see what this story means for you.
Reader-supported · The Brief
Liked this? The Brief brings you the whole day in tech, verified, every morning. Two minutes, free forever.
See what’s happening right now
The Feed runs all day — short, verified briefs the moment they break.
Open the FeedFollow @thecircuitry_
Every story we publish, as it happens. No noise between.
Reader-supported
The Circuitry is a passion project I've always wanted to build, and I love the work behind it.
Running it costs real money. APIs, hosting, time. To keep improving the site and growing this into something useful for everyone, those costs have to be covered.
Any contribution is appreciated. If not, no pressure. Thanks for reading.
MediaTek finalized pricing of a record US$3.9 billion overseas convertible bond on August 31, 2026, with Nvidia reportedly subscribing to US$3.5 billion or roughly 90 percent of the total. The issuance, which exceeds NT$120 billion, is described by the company as the largest overseas CB ever from a Taiwanese issuer.
Stripe has finalized an acquisition of AI gateway startup OpenRouter for more than $7 billion according to Bloomberg. The deal values the company far above its $1.3 billion valuation from a May funding round and brings a platform with 8 million users and access to over 400 models into Stripe's portfolio.
Kalshi is in advanced talks with Sequoia Capital and Wellington Management to raise at least $750 million at a $40 billion valuation. The round would nearly double its May valuation while the company reports $4 billion in annualized revenue and eyes a 2027 IPO.
